A Study in Healthy Volunteers to Assess Effect of AZD6765 on Midazolam Blood Levels
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the effect repeated doses of AZD6765 (a drug
being developed for the treatment of patients with severe major depressive disorder) has on
the PK (pharmacokinetic) profile of Midazolam. (The PK profile is how the drug leaves your
body and acts in the body.)